Seattle Children’s aims to outsmart cancer in a new trial – KING5.com
|
Seattle Children's aims to outsmart cancer in a new trial
KING5.com “Less than half those patients that relapse, about 40 percent, in our trial develop a CD 19 negative relapse, and what that means is that leukemia has evolved to become resistant and hide from the CD 19 CAR–T cell therapy,” said Corinne Summers … |
